[1]CurrentPatentAssignee:SYNERGENICSLCC-WO2014/66743,2014,A1Locationinpatent:Paragraph0146
[2]Naito,Youichiro;Akahoshi,Fumihiko;Takeda,Shinji;Okada,Takehiro;Kajii,Masahiko;Nishimura,Hiroko;Sugiura,Masanori;Fukaya,Chikara;Kagitani,Yoshio[JournalofMedicinalChemistry,1996,vol.39,#15,p.3019-3029]
[3]Bera,Hriday;Lee,MinHuey;Sun,Lingyi;Dolzhenko,AntonV.;Chui,WaiKeung[BioorganicChemistry,2013,vol.50,p.34-40]
[1]Naito,Youichiro;Akahoshi,Fumihiko;Takeda,Shinji;Okada,Takehiro;Kajii,Masahiko;Nishimura,Hiroko;Sugiura,Masanori;Fukaya,Chikara;Kagitani,Yoshio[JournalofMedicinalChemistry,1996,vol.39,#15,p.3019-3029]
[1]Naito,Youichiro;Akahoshi,Fumihiko;Takeda,Shinji;Okada,Takehiro;Kajii,Masahiko;Nishimura,Hiroko;Sugiura,Masanori;Fukaya,Chikara;Kagitani,Yoshio[JournalofMedicinalChemistry,1996,vol.39,#15,p.3019-3029]
[1]Dolzhenko,AntonV.;Kalinina,SvetlanaA.;Kalinin,DmitriiV.[RSCAdvances,2013,vol.3,#36,p.15850-15855]
[1]Bera,Hriday;Lee,MinHuey;Sun,Lingyi;Dolzhenko,AntonV.;Chui,WaiKeung[BioorganicChemistry,2013,vol.50,p.34-40]
Title: One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.
Journal: Journal of medicinal chemistry 20090723